We updated the design of this site on September 25th. Learn more.

Chinese Network of Pediatric Antiretroviral Therapy (CN-PART)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.

Verified November 2013 by National Center for AIDS/STD Control and Prevention, China CDC.
Recruitment status was: Recruiting

Sponsor:

ClinicalTrials.gov Identifier:

NCT01210924

First Posted: September 29, 2010

Last Update Posted: November 25, 2013

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

Information provided by (Responsible Party):

National Center for AIDS/STD Control and Prevention, China CDC

Purpose

This is an observational cohort in pediatric HIV patients in China. Children who receive antiretroviral drugs will be recruited in this study. The main objectives are as follows: 1. To establish simpler and smarter pediatric antiretroviral therapy in China including both first-line and second-line regimens. 2. To study the nature, characteristics and mechanisms of immunoreconstitution in HIV-infected children using the data and samples from the pediatric antiretroviral therapy cohort. 3. To establish a basic science and clinical research network based on the pediatric antiretroviral cohort.

Condition
Acquired Immunodeficiency Syndrome


Study Type:	Observational
Study Design:	Observational Model: Cohort Time Perspective: Prospective
Official Title:	Chinese Study of Pediatric Antiretroviral Therapy

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS

U.S. FDA Resources

Further study details as provided by National Center for AIDS/STD Control and Prevention, China CDC:

Biospecimen Retention: Samples With DNA

plamsa, PMBC, whole blood


Estimated Enrollment:	400
Study Start Date:	April 2010
Estimated Study Completion Date:	December 2015
Estimated Primary Completion Date:	December 2015 (Final data collection date for primary outcome measure)

Groups/Cohorts
Pediatric ART patients

Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:	up to 15 Years (Child)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Pediatric HIV-infected patients receiving triple antiretroviral drugs

Criteria

Inclusion Criteria:

clinical diagnosis of HIV infection
receiving triple antiretroviral drugs

Exclusion Criteria:

clinical status not stable

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01210924

Contacts


Contact: Fujie Zhang, MD	+861063039086	treatment@chinaaids.cn
Contact: Yan Zhao, MD	+861063039075	zhaoyanmgl@yahoo.com.cn

Locations


China
National Center for AIDS/STD Control and Prevention, China Center for Disease Control and Prevention	Recruiting
Beijing, China, 102206
Contact: Yan Zhao, MD +861063039075 zhaoyanmgl@yahoo.com.cn
Principal Investigator: Fujie Zhang, MD

Sponsors and Collaborators

National Center for AIDS/STD Control and Prevention, China CDC

Investigators


Principal Investigator:	Fujie Zhang, MD	National Center for AIDS/STD control and prevention

More Information


Responsible Party:	National Center for AIDS/STD Control and Prevention, China CDC
ClinicalTrials.gov Identifier:	NCT01210924 History of Changes
Other Study ID Numbers:	Pediatric treatment 2010 2008ZX10001-007 ( Other Grant/Funding Number: Chinese Ministory of Health )
First Submitted:	September 27, 2010
First Posted:	September 29, 2010
Last Update Posted:	November 25, 2013
Last Verified:	November 2013

Keywords provided by National Center for AIDS/STD Control and Prevention, China CDC:


children Acquired Immunodeficiency Syndrome antiretroviral therapy China Mortality

Additional relevant MeSH terms:


Immunologic Deficiency Syndromes Acquired Immunodeficiency Syndrome HIV Infections Immune System Diseases Lentivirus Infections Retroviridae Infections	RNA Virus Infections Virus Diseases Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Slow Virus Diseases

To Top